Alzheimer’s Disease: Current Perspectives and Advances in Physiological Modeling
Though Alzheimer’s disease (AD) is the most common cause of dementia, complete disease-modifying treatments are yet to be fully attained. Until recently, transgenic mice constituted most in vitro model systems of AD used for preclinical drug screening; however, these models have so far failed to ade...
Main Authors: | E. Josephine Boder, Ipsita A. Banerjee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/8/12/211 |
Similar Items
-
Dynamic microphysiological system chip platform for high-throughput, customizable, and multi-dimensional drug screening
by: Zhu, Yuxuan, et al.
Published: (2024) -
Advancements in the Application of Nanomedicine in Alzheimer’s Disease: A Therapeutic Perspective
by: Nidhi Puranik, et al.
Published: (2023-09-01) -
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
by: Wendy Balestri, et al.
Published: (2024-01-01) -
Critical appraisal on mitochondrial dysfunction in Alzheimer’s disease
by: Faizan Ahmad, et al.
Published: (2022-12-01) -
Accelerating the in vitro emulation of Alzheimer’s disease-associated phenotypes using a novel 3D blood-brain barrier neurosphere co-culture model
by: Eunkyung Clare Ko, et al.
Published: (2023-10-01)